Edition:
India

Alimera Sciences Inc (ALIM.OQ)

ALIM.OQ on NASDAQ Stock Exchange Global Market

6.61USD
21 Feb 2020
Change (% chg)

-- (--)
Prev Close
$6.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,670
52-wk High
$18.00
52-wk Low
$0.00

Latest Key Developments (Source: Significant Developments)

Alimera Sciences Inc Enters Purchase Agreement With Lincoln Park Capital Fund To Purchase Up To $20.0 Million Of Shares Of Co's Common Stock
Friday, 25 Oct 2019 

Oct 25 (Reuters) - Alimera Sciences Inc ::ALIMERA SCIENCES INC - ENTERED INTO A PURCHASE AGREEMENT WITH LINCOLN PARK CAPITAL FUND TO PURCHASE UP TO $20.0 MILLION OF SHARES OF CO'S COMMON STOCK.  Full Article

Alimera Sciences Announces Top Line Revenue Expectation For The Third Quarter Of 2019
Wednesday, 2 Oct 2019 

Oct 2 (Reuters) - Alimera Sciences Inc ::ALIMERA SCIENCES ANNOUNCES TOP LINE REVENUE EXPECTATION FOR THE THIRD QUARTER OF 2019.EXPECTS TO REPORT CONSOLIDATED NET REVENUE FOR Q3 OF 2019 EXCEEDING $12.8 MILLION.IN U.S. IN Q3, SAW SEQUENTIAL GROWTH OVER Q2.Q3 REVENUE VIEW $12.9 MILLION -- REFINITIV IBES DATA.  Full Article

Alimera Sciences Announces Second Quarter loss per share of $0.07
Tuesday, 30 Jul 2019 

July 29 (Reuters) - Alimera Sciences Inc ::ALIMERA SCIENCES ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE.Q2 GAAP LOSS PER SHARE $0.07.Q2 REVENUE $10.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF $13 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.04 -- REFINITIV IBES DATA.  Full Article

Alimera Says UK National Institute For Health And Care Excellence To Undertake Partial Review & Appraisal Of Technology Assessment 301
Monday, 11 Jun 2018 

June 11 (Reuters) - Alimera Sciences Inc ::ALIMERA - UK NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE TO UNDERTAKE PARTIAL REVIEW & APPRAISAL OF TECHNOLOGY ASSESSMENT 301.  Full Article

Alimera Sciences Terminates At-The-Market Offering Agreement
Monday, 4 Jun 2018 

June 4 (Reuters) - Alimera Sciences Inc ::ALIMERA SCIENCES TERMINATES AT-THE-MARKET OFFERING AGREEMENT.ALIMERA SCIENCES INC - TERMINATED ITS OCTOBER 2017 AGREEMENT FOR AN INVESTMENT BANK TO SELL UP TO $25 MILLION IN SHARES OF ITS COMMON STOCK.ALIMERA SCIENCES INC - ALIMERA HAS NOT SOLD AND WILL NOT SELL ANY SHARES UNDER THIS "AT--MARKET" EQUITY PROGRAM.ALIMERA SCIENCES INC - DO NOT HAVE ANY CURRENT PLANS TO RAISE CAPITAL AND THEREFORE DO NOT BELIEVE WE NEED AN ATM IN PLACE.  Full Article